KCM
CELG

Kingdon Capital Management’s Celgene Corp CELG Stock Holding History

Kingdon Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-200,400
Closed -$17.9M – 148
2018
Q1 		$17.9M Buy
+200,400
New +$19.2M 1.41% 20

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Kingdon Capital Management's CELG Position: Q2 2019 in Review

Kingdon Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 254,244 shares — an estimated $24M sold.

Kingdon Capital Management first reported a position in CELG in Q3 2013 and held it in 3 quarters. The position peaked at $24M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Kingdon Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Kingdon Capital Management sold 254,244 Celgene Corp shares in Q2 2019, an estimated $24M.
  • Kingdon Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 3 quarters.
  • Kingdon Capital Management's Celgene Corp position peaked at $24M in Q1 2019.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.